51 related articles for article (PubMed ID: 8831679)
21. Retinoid signaling is attenuated by proteasome-mediated degradation of retinoid receptors in human keratinocyte HaCaT cells.
Boudjelal M; Voorhees JJ; Fisher GJ
Exp Cell Res; 2002 Mar; 274(1):130-7. PubMed ID: 11855864
[TBL] [Abstract][Full Text] [Related]
22. Proteasome inhibitors and antigen presentation.
Bogyo M; Gaczynska M; Ploegh HL
Biopolymers; 1997; 43(4):269-80. PubMed ID: 9316392
[TBL] [Abstract][Full Text] [Related]
23. Apolipoprotein E in macrophages and hepatocytes is eegraded via the proteasomal pathway.
Wenner C; Lorkowski S; Engel T; Cullen P
Biochem Biophys Res Commun; 2001 Mar; 282(2):608-14. PubMed ID: 11401504
[TBL] [Abstract][Full Text] [Related]
24. Tightly regulated and inducible expression of rabbit CYP2E1 using a tetracycline-controlled expression system.
Huan JY; Koop DR
Drug Metab Dispos; 1999 Apr; 27(4):549-54. PubMed ID: 10101151
[TBL] [Abstract][Full Text] [Related]
25. Interferon gamma enhances proteasome activity in recombinant Hep G2 cells that express cytochrome P4502E1: modulation by ethanol.
Osna NA; Clemens DL; Donohue TM
Biochem Pharmacol; 2003 Sep; 66(5):697-710. PubMed ID: 12948850
[TBL] [Abstract][Full Text] [Related]
26. Differential degradation of the three fibrinogen chains by proteasomes: involvement of Sec61p and cytosolic Hsp70.
Xia H; Redman CM
Arch Biochem Biophys; 2001 Jun; 390(1):137-45. PubMed ID: 11368525
[TBL] [Abstract][Full Text] [Related]
27. Proteasome-dependent degradation of cytosolic chaperonin CCT.
Yokota S; Kayano T; Ohta T; Kurimoto M; Yanagi H; Yura T; Kubota H
Biochem Biophys Res Commun; 2000 Dec; 279(2):712-7. PubMed ID: 11118350
[TBL] [Abstract][Full Text] [Related]
28. The amino-terminal domain of apolipoprotein B does not undergo retrograde translocation from the endoplasmic reticulum to the cytosol. Proteasomal degradation of nascent apolipoprotein B begins at the carboxyl terminus of the protein, while apolipoprotein B is still in its original translocon.
Liang S; Wu X; Fisher EA; Ginsberg HN
J Biol Chem; 2000 Oct; 275(41):32003-10. PubMed ID: 10922368
[TBL] [Abstract][Full Text] [Related]
29. Evidence of proteasome-mediated cytochrome P-450 degradation.
Roberts BJ
J Biol Chem; 1997 Apr; 272(15):9771-8. PubMed ID: 9092510
[TBL] [Abstract][Full Text] [Related]
30. Degradation of methoxysuccinyl-phe-leu-phe-7-amido-4-trifluoromethyl coumarin (FLF) in cultured myotubes and HepG2 cells is proteasome- and calpain/calcium-dependent.
Li BG; Fang CH; Hasselgren P
Int J Biochem Cell Biol; 2000 Jun; 32(6):677-86. PubMed ID: 10785364
[TBL] [Abstract][Full Text] [Related]
31. Ethanol-related cytotoxicity catalyzed by CYP2E1-dependent generation of reactive oxygen intermediates in transduced HepG2 cells.
Cederbaum AI
Biofactors; 1998; 8(1-2):93-6. PubMed ID: 9699015
[TBL] [Abstract][Full Text] [Related]
32. Ca2+-dependent and independent mitochondrial damage in HepG2 cells that overexpress CYP2E1.
Caro AA; Cederbaum AI
Arch Biochem Biophys; 2002 Dec; 408(2):162-70. PubMed ID: 12464267
[TBL] [Abstract][Full Text] [Related]
33. Intracellular degradation of histidine-rich glycoprotein mutants: tokushima-1 and 2 mutants are degraded by different proteolytic systems.
Wakabayashi S; Yoshida H; Shigekiyo T; Koide T
J Biochem; 2000 Aug; 128(2):201-6. PubMed ID: 10920255
[TBL] [Abstract][Full Text] [Related]
34. Increased proteolysis after single-dose exposure with hepatotoxins in HepG2 cells.
Pirlich M; Müller C; Sandig G; Jakstadt M; Sitte N; Lochs H; Grune T
Free Radic Biol Med; 2002 Jul; 33(2):283-91. PubMed ID: 12106824
[TBL] [Abstract][Full Text] [Related]
35. Selective fast degradation of cytochrome P-450 2E1 in serum-deprived hepatoma cells by a mechanism sensitive to inhibitors of vesicular transport.
Zhukov A; Ingelman-Sundberg M
Eur J Biochem; 1997 Jul; 247(1):37-43. PubMed ID: 9249006
[TBL] [Abstract][Full Text] [Related]
36. An inhibitor of the chymotrypsin-like activity of the proteasome (PSI) induces similar morphological changes in various cell lines.
Wójcik C
Folia Histochem Cytobiol; 1997; 35(4):211-4. PubMed ID: 9619420
[TBL] [Abstract][Full Text] [Related]
37. Role of the proteasome complex in degradation of human CYP2E1 in transfected HepG2 cells.
Yang MX; Cederbaum AI
Biochem Biophys Res Commun; 1996 Sep; 226(3):711-6. PubMed ID: 8831679
[TBL] [Abstract][Full Text] [Related]
38. Characterization of cytochrome P4502E1 turnover in transfected HepG2 cells expressing human CYP2E1.
Yang MX; Cederbaum AI
Arch Biochem Biophys; 1997 May; 341(1):25-33. PubMed ID: 9143349
[TBL] [Abstract][Full Text] [Related]
39. NADPH-dependent microsomal electron transfer increases degradation of CYP2E1 by the proteasome complex: role of reactive oxygen species.
Goasduff T; Cederbaum AI
Arch Biochem Biophys; 1999 Oct; 370(2):258-70. PubMed ID: 10510285
[TBL] [Abstract][Full Text] [Related]
40. CYP2E1 degradation by in vitro reconstituted systems: role of the molecular chaperone hsp90.
Goasduff T; Cederbaum AI
Arch Biochem Biophys; 2000 Jul; 379(2):321-30. PubMed ID: 10898951
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
